Trigano S.A. (LON:0NX0)
London · Delayed Price · Currency is GBP · Price in EUR 173.00
+2.70 (1.59%)
At close: Dec 16, 2025
Trigano Revenue
In the fiscal year ending August 31, 2025, Trigano had annual revenue of 3.66B EUR, down -6.78%. Trigano had revenue of 1.99B in the half year ending August 31, 2025, with 6.10% growth.
Revenue
3.66B EUR
Revenue Growth
-6.78%
P/S Ratio
0.92
Revenue / Employee
343.62K EUR
Employees
10,652
Market Cap
2.92B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 3.66B | -266.10M | -6.78% |
| Aug 31, 2024 | 3.93B | 446.10M | 12.82% |
| Aug 31, 2023 | 3.48B | 303.00M | 9.54% |
| Aug 31, 2022 | 3.18B | 243.60M | 8.30% |
| Aug 31, 2021 | 2.93B | 749.58M | 34.32% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |